- 2019: Start of the worldwide distribution of the Bactrim®
- 2018: A third of the top ten pharmaceutical multinationals selects Eumedica for the distribution of their clinical trial products worldwide
- 2016: Eumedica’s 30 year anniversary
- 2015: Launch of Negaban® in France
- 2014: Increase of our storage capacities (up to 10,000 m²)
- 2013: Distribution of the antipsychotics product range (Dipiperon®, Orap®, Imap®, Impromen Decanoas® and Impromen®)
- 2012: Extension of our logistics centre
- 2009: Distribution of Somatostatine-Eumedica® worldwide
- 2007: Another of the top ten pharmaceutical multinationals trusts Eumedica for the distribution of their clinical trial products worldwide except US and South America
- 2006: Launch of Negaban® in the United Kingdom
- 2006: Launch of Somatostatine-Belpharma® in Belgium
- 2004: Launch of Actosolv® in France
- 2003: Eumedica moves to its new distribution centre in Manage
- 2002: Expansion of Eumedica’s product portfolio with the: Dopram®, Robinul®, and Robinul Neostigmine®, Actosolv®
- 2002: One of the largest pharmaceutical multinationals chooses Eumedica to distribute their clinical trial products worldwide
- 1998: Distribution of the Negaban® (Temocillin)
- 1986: Creation
This website uses cookies to improve your experience. You may block the use of cookies, however, some are essential for the website to operate properly. Please select “Accept” below to confirm that you have read and accept the terms of our cookie policy.Accept Read More Privacy & Cookies Policy
